| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MDS.1246 |
| P698 | PubMed publication ID | 11835443 |
| P50 | author | Patrick P Michel | Q41634796 |
| P2093 | author name string | Merle Ruberg | |
| Annie Lannuzel | |||
| Reynald Hocquemiller | |||
| Dominique Caparros-Lefebvre | |||
| Jacqueline Abaul | |||
| P2860 | cites work | Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice | Q71562858 |
| Food toxins, ampa receptors, and motor neuron diseases | Q33719813 | ||
| Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group | Q33870291 | ||
| Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features | Q34540135 | ||
| Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity | Q37683630 | ||
| 1-Methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells is enhanced by preventing glycolysis | Q41142735 | ||
| Unlike MPP+, apoptosis induced by 6-OHDA in PC12 cells is independent of mitochondrial inhibition | Q41144028 | ||
| Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility | Q42154993 | ||
| Dopaminergic and cholinergic lesions in progressive supranuclear palsy | Q42205368 | ||
| Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA. | Q42488056 | ||
| Isoquinoline derivatives isolated from the fruit of Annona muricata as 5-HTergic 5-HT1A receptor agonists in rats: unexploited antidepressive (lead) products. | Q42833941 | ||
| Synthesis and dopamine receptor selectivity of the benzyltetrahydroisoquinoline, (R)-(+)-nor-roefractine | Q47918192 | ||
| Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes | Q48227423 | ||
| The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra | Q48245002 | ||
| Cryopreservation of primary neurons for tissue culture | Q48290194 | ||
| Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle | Q48371514 | ||
| Effects of d-coclaurine and d-reticuline, benzyltetrahydroisoquinoline alkaloids, on levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid in the mouse striatum | Q48736503 | ||
| [Alkaloids of Annonaceae. XXIX. Alkaloids of Annona muricata]. | Q52539611 | ||
| Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex | Q57820816 | ||
| Reticuline: a dopamine receptor blocker | Q70649966 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| dopamine | Q170304 | ||
| Guadeloupe | Q17012 | ||
| Annonaceae | Q220025 | ||
| parkinsonian syndrome | Q1531991 | ||
| P304 | page(s) | 84-90 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe | |
| P478 | volume | 17 |
| Q37575649 | ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs |
| Q38667045 | Acetogenins from Annonaceae. |
| Q37718187 | Alkaloids from the genus Duguetia |
| Q93078233 | Annona cherimola Seed Extract Activates Extrinsic and Intrinsic Apoptotic Pathways in Leukemic Cells |
| Q46268493 | Annonaceae: Breaking the Wall of Inflammation. |
| Q28475734 | Chemicals possessing a neurotrophin-like activity on dopaminergic neurons in primary culture |
| Q38749513 | Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild-type and MAPT transgenic mice. |
| Q53178012 | Emerging therapeutic potential of graviola and its constituents in cancers. |
| Q45076842 | Experimental evidence for a toxic etiology of tropical parkinsonism |
| Q37082071 | How to improve neuroprotection in Parkinson's disease? |
| Q34571137 | Is atypical parkinsonism in the Caribbean caused by the consumption of Annonacae? |
| Q33881998 | Kaurenoic acid from pulp of Annona cherimolia in regard to Annonaceae-induced Parkinsonism |
| Q36994301 | Neurodegenerative diseases: neurotoxins as sufficient etiologic agents? |
| Q30810295 | Progressive supranuclear palsy: where are we now? |
| Q34581908 | REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy. |
| Q28169166 | Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels |
| Q46728310 | Risk factors of multiple system atrophy: a case-control study in French patients |
| Q36049419 | Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancer |
| Q33761048 | Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. |
| Q41682166 | The Annona muricata leaf ethanol extract affects mobility and reproduction in mutant strain NB327 Caenorhabditis elegans |
| Q33972895 | The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. |
| Q26852384 | The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations |
| Q89805038 | Xenobiotics, Trace Metals and Genetics in the Pathogenesis of Tauopathies |
Search more.